|
| Sunday, November 13, 2022 |
|
|
Legend Capital Portfolio Company Atour Successfully Lists on Nasdaq |
| On the evening of November 11, Beijing time, Legend Capital portfolio company Atour Lifestyle Holdings Limited ("Atour") was officially listed on the Nasdaq Stock Exchange in the United States. It has priced its initial public offering of 4,750,000 American Depositary Shares ("ADSs") at US$11.0 per ADS. more info >> |
|
| Thursday, November 10, 2022 |
|
|
Led by Legend Capital, PureFDA Secures Over CNY100 million in the Series B Round |
| Recently, PureFDA Medical Technology (Guangzhou) Co., LTD. (hereinafter referred to as "PureFDA") announced the completion of the Series B round of financing of over CNY100 million, which was led by Legend Capital and followed by the existing shareholder Bayland Capital. more info >> |
|
| Monday, November 7, 2022 |
|
|
Legend Capital Portfolio Company Giant Biogene Successfully Lists on the HKEX |
| On November 4, 2022, Legend Capital portfolio company Giant Biogene (2367.HK) was successfully listed on the main board of the Hong Kong Stock Exchange. more info >> |
|
| Tuesday, November 1, 2022 |
|
|
Led by Legend Capital, ClinBrain Completes Nearly CNY200 million Series C Round |
| Recently, the healthcare big data leader ClinBrain completed the Series C round of financing of nearly CNY200 million, led by Legend Capital. more info >> |
|
|
Led by Legend Capital, Easy-Flow Raises Tens of Millions of CNY in Angel Round |
| Shanghai Easy-Flow ("Easy-Flow") recently completed its Angel financing round by raising tens of millions of CNY, led by Legend Capital. The fresh capital will be used for the R&D of Easy-Flow's peripheral intervention pipeline. more info >> |
|
| Thursday, October 20, 2022 |
|
|
Co-Led by Legend Capital, Top Gene Delivery Enterprise VectorBuilder Secures CNY410mn in Series C Round |
| VectorBuilder Biotechnology (Guangzhou) Co., Ltd. (hereinafter referred to as "VectorBuilder"), a top gene delivery enterprise, recently announced the completion of its Series C round with CNY410 million, co-led by Legend Capital. more info >> |
|
| Sunday, September 25, 2022 |
|
|
GalaxySpace Completes a New Financing Round with Legend Capital Re-upped |
| GalaxySpace, a Chinese commercial aerospace company, recently completed its latest financing round with a post-investment valuation of approximately RMB11 billion. more info >> |
|
|
Leadrive Technology Completes Series C Financing, Legend Capital Re-upped |
| Leadrive Technology, a leading supplier of power semiconductor and motor control solutions for new energy vehicles, recently announced its completion of the series C financing. As the existing shareholder, Legend Capital continued to support this round of financing. more info >> |
|
| Friday, September 2, 2022 |
|
|
Legend Capital: The Logic of Technology Investment Has Changed |
| Legend Capital recently announced that it made its 100th IPO following the listing of its AI medical portfolio company Lunit on the KOSDAQ market on 21 July 2022. more info >> |
|
| Friday, August 19, 2022 |
|
|
Led by Legend Capital, Multi-omics-leading Enterprise APTBIO Closes Series B with Hundreds of Millions of CNY |
| Shanghai Applied Protein Technology Co., Ltd. ("APTBIO"), a leading enterprise focused on mass spectrometry-based multi-omics applied to precision medicine, recently announced the completion of its Series B with hundreds of millions of CNY, which is led by Legend Capital. more info >> |
|
|
|
